The tropomyosin family as novel biomarkers in relation to poor prognosis in glioma

HIGHLIGHTS

• who: Ke Huang et al. from the (UNIVERSITY) have published the paper: The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma, in the Journal: Biology 2022, 1115 of /2022/
• what: The authors conducted an in-depth and comprehensive analysis of the expression of TPMs in glioma and evaluated their potential as prognostic biomarkers based on TCGA data, thus providing additional data to help clinicians more accurately assess the long-term outcome prognosis in patients with glioma. In this study, six types of infiltrating immune cells in low-grade glioma (LGG) and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.